Discussion Topic: Arrhythmic Prognosis According to Left Ventricular Systolic Dysfunction Severity in Cardiac Sarcoidosis
William H. Sauer, MD, FHRS, CCDS, Brigham and Women’s Hospital is joined by Edoardo Bressi, MD Queen Elizabeth Hospital – University Hospitals Birmingham, and Jordana Kron, MD Virginia Commonwealth University to discuss the current guidelines that present varying classes of recommendations for implantable cardioverter-defibrillator (ICD) utilization in patients with cardiac sarcoidosis (CS) and left ventricular ejection fraction (LVEF) <50%. This podcast episode explores a manuscript describing outcomes in these patients.
Host: William H. Sauer, MD, FHRS, CCDS
Guests: Jordana Kron, MD and Edoardo Bressi, MD
Speaker and Article Information: Download
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 128: A Discussion of Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation: The ALONE-AF Randomized Clinical Trial
December 4, 2025
HRX Next
Podcasts
HRX NeXt Ep. 3 – A Conversation about Understanding AI Bias in Clinical Practice
December 3, 2025
The Lead
Podcasts
The Lead Episode 127 A Discussion of Remote Screening for Asymptomatic Atrial Fibrillation: The AMALFI Randomized Clinical Trial
November 20, 2025